Interesting findings & congrats first author Dr Catherine Derington & coauthors👏👏
Similar findings in Italian women receiving beta blockers as first line Rx for #Hypertension
Dr Derington was my #Hypertension24 CHAMP Mentee & very proud👏
Look fwd to reuniting #Hypertension25
Similar findings in Italian women receiving beta blockers as first line Rx for #Hypertension
Dr Derington was my #Hypertension24 CHAMP Mentee & very proud👏
Look fwd to reuniting #Hypertension25
September 3, 2025 at 11:06 PM
Interesting findings & congrats first author Dr Catherine Derington & coauthors👏👏
Similar findings in Italian women receiving beta blockers as first line Rx for #Hypertension
Dr Derington was my #Hypertension24 CHAMP Mentee & very proud👏
Look fwd to reuniting #Hypertension25
Similar findings in Italian women receiving beta blockers as first line Rx for #Hypertension
Dr Derington was my #Hypertension24 CHAMP Mentee & very proud👏
Look fwd to reuniting #Hypertension25
Proud mentor 📣 at #Hypertension24!
@RushelleByfield nailed her oral abstract describing how ambulatory BP variability was NOT associated with adverse kidney & CV outcomes after robust adjustment in a large US cohort of patients with CKD @CRICStudy followed for >9 years
@RushelleByfield nailed her oral abstract describing how ambulatory BP variability was NOT associated with adverse kidney & CV outcomes after robust adjustment in a large US cohort of patients with CKD @CRICStudy followed for >9 years
November 22, 2024 at 9:38 AM
Proud mentor 📣 at #Hypertension24!
@RushelleByfield nailed her oral abstract describing how ambulatory BP variability was NOT associated with adverse kidney & CV outcomes after robust adjustment in a large US cohort of patients with CKD @CRICStudy followed for >9 years
@RushelleByfield nailed her oral abstract describing how ambulatory BP variability was NOT associated with adverse kidney & CV outcomes after robust adjustment in a large US cohort of patients with CKD @CRICStudy followed for >9 years
Amazing job @PharmDerington presenting our VA data showing surprisingly high use of beta-blockers as first-line antihypertensive therapy despite the absence of compelling indications @adambress #Hypertension24
November 22, 2024 at 9:38 AM
Amazing job @PharmDerington presenting our VA data showing surprisingly high use of beta-blockers as first-line antihypertensive therapy despite the absence of compelling indications @adambress #Hypertension24